Overview

Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN

Status:
Active, not recruiting

Trial end date:
2022-01-01

Target enrollment:

Participant gender:

Summary

This multicentre, randomised Phase II Pilot Study evaluates the efficacy of docetaxel, cisplatin and 5-fluorouracil or Cetuximab, followed by Cetuximab with radiotherapy.

Phase:

Phase 2

Details

Lead Sponsor:

Arbeitsgemeinschaft medikamentoese Tumortherapie

Treatments:

Cetuximab
Cisplatin
Docetaxel
Fluorouracil